| |

Interview with Bright Minds Biosciences’ CEO Ian McDonald

BySarah Abelsohn



In today’s episode of the Psychedelic Spotlight podcast, the Psychedelic Investor, James Hallifax interviews Ian McDonald, CEO and Director of Bright Minds Biosciences. For any investors out there, you can find Bright Minds Biosciences trading on the Canadian Securities Exchange under the symbol $DRUG and on the American OTC market under the symbol $BMBIF.

In this wide ranging interview many topics are covered, starting with the philosophy and vision of Bright Minds. We discuss most of Bright Minds’ major projects, including using new psychedelic medicines to treat chronic pain. This is exciting, since it could not only help people with chronic pain issues such as fibromyalgia, but it could also put a dent in the opioid use crisis by preventing people from being prescribed opioids by their doctors to treat pain.

Bright Minds is a company working on second and third generation psychedelics to treat a variety of ailments including depression, PTSD, epilepsy, addiction and more. The driving philosophy is that while classic psychedelics such as psilocybin and LSD do show great potential to be used in a therapy setting to treat mental health issues, the compounds also have limitations. At Bright Minds, the goal is to engineer completely new compounds, often based on the structure of classical psychedelics, that keep the benefits of said drugs while doing away with potential negatives. Important to note is that while psychedelic derived drugs are a focus of the company, they also are creating non-psychedelic compounds for a variety of ailments, including different forms of addiction.

*To learn more about Bright Minds Biosciences, visit their website: https://BrightMindsBio.com

*Subscribe to our newsletter to get the latest industry news: https://PsychedelicSpotlight.com

#psychedelics #mentalhealth #biotech

source

Similar Posts

  • Interview with Matt Zemon, Co-Founder, Psychable

    Listen, Podcasts

    In our conversation with Matt, we tackle a variety of extremely important and highly-relevant subject matters such as how technology can be utilized to enhance the community of psychedelic healing, conscious capitalism, corporate responsibility, and how companies like Psychable are willing to go out of their way to connect with investors who are motivated not only by profit, but a company’s ability to contribute to the greater good of humanity.

  • New Psychedelic ETF (PSYK) UPDATE: What Does This Mean For MindMed, NUMI & Compass Pathways?

    Listen, Videos

    In our previous video, we discussed the upcoming IPO of Horizons Psychedelic ETF (PSYK).
    Recently, on January 27th, PSYK began trading on the Canadian NEO Stock Exchange.
    In this episode we are going to discuss the psychedelic ETF and what it means for MindMed, NUMI, Compass Pathways and other stocks in the psychedelic sector.

    We will cover a few things such as:

    – PSYK’s fundamentals
    – PSYK’s CEO Steve Hawkins
    -Is Horizons ETF actively or passively managed?
    – What psychedelic stocks are included in the ETF?
    – How often does th ETF reorganize its stock holdings?
    – How is the size of the individual stocks’ position decided on?
    – Is it worth investing in PSYK now?
    – What will happen to MindMed (MMED/MMEDF), Numinus Wellness (NUMI), Compass Pathways (CMPS) and the other stocks once they are included?

    ***A quick reminder, the psychedelic sector is at a VERY early stage, and all of these companies, large-cap and small cap alike, will need to attract more funding to complete their clinical trials and bring their products to market. PSYK will however contribute to this sector as it will bring more funding to the industry as a whole, which will both help individual companies and the wider mission of treating mental health disorders.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #PSYK #MindMed #MMED

  • MindMed Conference Call Recap & My THOUGHTS (MMED / MNMD)

    Listen, Videos

    Hey guys! Here’s the recap of MindMed’s (MMED / MNMD/ MMQ) Q1 conference call. They added lots of color on their different projects, and provided us with a lot of interesting new information. So, in this episode, we will cover a few topics. These are:

    1. MindMed’s Mission
    2. Their Talent acquisition
    3. The Progress of their different clinical trials
    4. The future

    Timestamps:
    0:00 – Intro
    1:59 – MindMed’s Mission
    4:36 – MMED’s talent acquisition
    7:24 – MindMed’s clinical trial progress
    10:48 – Psychiatry department : Project Lucy
    14:17 – Addiction department : Project Layla (18MC)
    18:33 – Pain department: Project Angie to treat pain card
    22:56 – Neurology department: Project Flow using LSD microdosing to treat ADHD
    23:43 – MindMed (MMED / MNMD) and its future plans

    Enjoy!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #MNMD

  • MindMed: What Does The Future Hold? ( MMED/ MNMD )

    Listen, Videos

    Hey guys! Today, we’ll cover Part 2 of our discussion on MindMed’s (MMED / MNMD / MMQ) conference call.
    In the previous episode, we talked about the progress MindMed has made up until this point, MindMed’s mission, talent Acquisition, and the progress of their clinical trials.

    In today’s episode, we will take a more futuristic approach and examine the future plans discussed in MindMed’s Q1 conference call. We will cover topics such as:

    A. Where is MindMed going?
    B. What is MindMed 2.0?
    C. What will MindMed in 3 years time look like as compared to now?

    Over the next several years, we expect 4 transformations to occur.
    1. MindMed’s transition to a tech company, from a pharmaceuticals company;
    2. The shift from classic psychedelics like LSD to “next generation” patent protected substances;
    3. Reorientation away from one size fits all medical solutions towards personalized medicine;
    4. Finding Partnerships with major pharmaceutical companies.

    Timestamps:
    0:00 – Intro
    2:16 – MindMed transitioning to a tech company
    7:14 -Next-gen shift
    12:11 – Personalized medicine
    13:59 – Partnerships

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #MNMD #MindMedstock